nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—NR3C1—Spironolactone—dilated cardiomyopathy	0.414	1	CbGbCtD
Amcinonide—Cortisone acetate—Spironolactone—dilated cardiomyopathy	0.197	0.362	CrCrCtD
Amcinonide—Fluoxymesterone—Spironolactone—dilated cardiomyopathy	0.176	0.323	CrCrCtD
Amcinonide—Fludrocortisone—Spironolactone—dilated cardiomyopathy	0.171	0.315	CrCrCtD
Amcinonide—ANXA1—cardiac ventricle—dilated cardiomyopathy	0.00301	0.235	CbGeAlD
Amcinonide—ANXA1—myocardium—dilated cardiomyopathy	0.00283	0.221	CbGeAlD
Amcinonide—ANXA1—heart—dilated cardiomyopathy	0.00198	0.154	CbGeAlD
Amcinonide—ANXA1—cardiac atrium—dilated cardiomyopathy	0.00169	0.132	CbGeAlD
Amcinonide—Fludrocortisone—NR3C2—dilated cardiomyopathy	0.00135	0.296	CrCbGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00111	0.0438	CbGpPWpGaD
Amcinonide—NR3C1—cardiac ventricle—dilated cardiomyopathy	0.00105	0.0816	CbGeAlD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—NR3C2—dilated cardiomyopathy	0.00101	0.0398	CbGpPWpGaD
Amcinonide—NR3C1—myocardium—dilated cardiomyopathy	0.000983	0.0768	CbGeAlD
Amcinonide—Fluticasone Propionate—NR3C2—dilated cardiomyopathy	0.000948	0.208	CrCbGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ZBTB17—dilated cardiomyopathy	0.000943	0.0373	CbGpPWpGaD
Amcinonide—Prednisolone—NR3C2—dilated cardiomyopathy	0.000887	0.194	CrCbGaD
Amcinonide—ANXA1—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.000879	0.0348	CbGpPWpGaD
Amcinonide—Betamethasone—NR3C2—dilated cardiomyopathy	0.000869	0.191	CrCbGaD
Amcinonide—NR3C1—heart—dilated cardiomyopathy	0.000686	0.0536	CbGeAlD
Amcinonide—ANXA1—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000653	0.0258	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.0006	0.0238	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.0006	0.0238	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000594	0.0235	CbGpPWpGaD
Amcinonide—NR3C1—cardiac atrium—dilated cardiomyopathy	0.000587	0.0458	CbGeAlD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.000558	0.0221	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.000507	0.02	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.000507	0.02	CbGpPWpGaD
Amcinonide—Dexamethasone—NR3C2—dilated cardiomyopathy	0.000505	0.111	CrCbGaD
Amcinonide—ANXA1—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000498	0.0197	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.000491	0.0194	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000471	0.0186	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.000468	0.0185	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.000462	0.0183	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000423	0.0167	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000418	0.0166	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000409	0.0162	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000403	0.0159	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000403	0.0159	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000374	0.0148	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000363	0.0143	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000358	0.0142	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000345	0.0137	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000339	0.0134	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000329	0.013	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.000325	0.0129	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	0.000313	0.0124	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00031	0.0123	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000307	0.0121	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000307	0.0121	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000294	0.0116	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000294	0.0116	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000285	0.0113	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000276	0.0109	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000274	0.0108	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL10—dilated cardiomyopathy	0.000272	0.0108	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—dilated cardiomyopathy	0.000261	0.0103	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—LMNA—dilated cardiomyopathy	0.000254	0.0101	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—dilated cardiomyopathy	0.000242	0.00957	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000236	0.00933	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—AGT—dilated cardiomyopathy	0.000228	0.00903	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000226	0.00896	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000225	0.00889	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000224	0.00885	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000218	0.00862	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000216	0.00853	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000204	0.00808	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	0.000186	0.00735	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NR3C2—dilated cardiomyopathy	0.000174	0.00688	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000173	0.00686	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000173	0.00686	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000166	0.00657	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000165	0.00653	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000161	0.00638	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000157	0.00623	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000157	0.00623	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000156	0.00618	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000154	0.00609	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—FAS—dilated cardiomyopathy	0.000148	0.00588	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000147	0.0058	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000146	0.00579	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000143	0.00567	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000142	0.00561	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00014	0.00554	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—AGT—dilated cardiomyopathy	0.000139	0.0055	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000133	0.00527	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000126	0.005	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000121	0.00479	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000115	0.00454	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	0.000109	0.00432	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000105	0.00414	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.82e-05	0.00388	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.38e-05	0.00371	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.3e-05	0.00368	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.3e-05	0.00368	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.91e-05	0.00353	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.64e-05	0.00342	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—AGT—dilated cardiomyopathy	8.52e-05	0.00337	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.37e-05	0.00331	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NR3C2—dilated cardiomyopathy	8.37e-05	0.00331	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.15e-05	0.00283	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.78e-05	0.00268	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—dilated cardiomyopathy	6.3e-05	0.00249	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.91e-05	0.00234	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.83e-05	0.00231	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.45e-05	0.00216	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.27e-05	0.00208	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NPPA—dilated cardiomyopathy	5.26e-05	0.00208	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—AGT—dilated cardiomyopathy	5.03e-05	0.00199	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.05e-05	0.0016	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.49e-05	0.00138	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.39e-05	0.000947	CbGpPWpGaD
